Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
GenoScreen logo — 🧬 Genomic services and innovative solutions in genomics▪️+5...

GenoScreen

🧬 Genomic services and innovative solutions in genomics▪️+500 projects each year▪️+27 research partners worldwide

Founded 2001 France France 38 employees Venture round Biotechnology, Health Care

General Information

Company Name GenoScreen
Founded Year 2001
Location France France
Employees 38
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with GenoScreen. To contact GenoScreen, visit genoscreen.fr.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does GenoScreen compare?

A PDF of GenoScreen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting GenoScreen soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About GenoScreen

GenoScreen is an innovative biotechnology company founded in 2001 in France. With a focus on genomics, the company offers a wide range of genomic services and innovative solutions for various sectors including healthcare, environment, agronomy, agriculture, agri-food, and skincare. The company's key offerings include molecular biology analyses, deep sequencing-based kits, and expertise and consultancy services for genomics projects. Additionally, GenoScreen provides custom-made training programs for individuals seeking to enhance their knowledge in genomic analyses. GenoScreen has garnered significant recognition over the years, with a 25% of its 40 employees holding PhD degrees, and 30% of its turnover reinvested in R&D. The company has also achieved ISO certifications: ISO13485 & ISO9001. Its global reach is evident with representation from more than 50 countries among its customer base and 400 active clients. Through its continuous commitment to innovation and excellence, GenoScreen has positioned itself as a leading player in the genomics industry. The company's recent Venture Round investment at 01 January 2005 was facilitated by FINORPA. This investment reflects the confidence of investors in the potential and growth prospects of GenoScreen, signifying a positive outlook for the company's future advancements.

Business keywords: Genomic services, DNA sequencing, Molecular biology analyses, Genotyping, Gene mutation detection, Metagenomics analysis, Microbial diagnosis, Consultancy services, Custom-made trainings, Bioinformatics, Healthcare solutions, Environmental solutions, Agronomy & agriculture solutions

Services & Products

Genomic Analysis
Microbial Characterization and Tracing
Sequencing
Genotyping
Gene Expression
Bioinformatics

Target Customers

Commercial and academic entities in healthcare cosmetics biodiversity agro-industry and nutrition sectors.

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
FINORPA
FINORPA
01 Jan 2005
Venture Round Undisclosed 1
FINORPA
FINORPA
01 Sep 2002
Non Equity Assistance Undisclosed 1
Eurasante
22 Dec 2000

GenoScreen Alternatives & Competitors

View All Alternatives
GenoScreen vs
Oxford Nanopore Technologies
Oxford Nanopore Technologies United Kingdom

Our goal is to enable the analysis of anything, by anyone, anywhere.

Post-IPO Equity
1341 employees
Biopharma, Biotechnology
Compare GenoScreen vs Oxford Nanopore Technologies
GenoScreen vs
BMR Genomics
BMR Genomics Italy

Empowering Research, Enhancing Lives Through Genomics.

20 employees
Biotechnology, Health Care
Compare GenoScreen vs BMR Genomics
GenoScreen vs
Intelliseq
Intelliseq

Master Genomic Analysis: User-Friendly, Adaptable & Comprehensive solution for Professionals

Venture round
18 employees
AI, Analytics
View all alternatives

FAQ About GenoScreen

🧬 Genomic services and innovative solutions in genomics▪️+500 projects each year▪️+27 research partners worldwide
GenoScreen was founded in 2001.
GenoScreen is headquartered in France.
GenoScreen operates in Biotechnology and Health Care. Its work centres on Genomic services, DNA sequencing, Molecular biology analyses and Genotyping. Its customers include Commercial and academic entities in healthcare, cosmetics and biodiversity.
GenoScreen has approximately 38 employees.
GenoScreen has completed 3 funding rounds. The latest funding stage is Venture round.
GenoScreen offers: Genomic Analysis, Microbial Characterization and Tracing, Sequencing, Genotyping, Gene Expression, Bioinformatics.
Top alternatives and competitors to GenoScreen include Oxford Nanopore Technologies, BMR Genomics, Intelliseq, Strand Life Sciences, CosmosID. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GenoScreen and Oxford Nanopore Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for GenoScreen, https://bouncewatch.com/company/genoscreen, updated 7 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes